Evidence supporting the use of: Sardines
For the health condition: Blood Clots (prevention of)

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Sardines are considered beneficial in the prevention of blood clots primarily due to their high content of omega-3 fatty acids, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Scientific studies have demonstrated that omega-3 fatty acids can reduce platelet aggregation, lower blood triglyceride levels, decrease inflammation, and modestly lower blood pressure—all of which contribute to a reduced risk of thrombosis (the formation of blood clots). Several randomized controlled trials and observational studies have indicated that regular consumption of oily fish, such as sardines, is associated with a lower incidence of cardiovascular diseases, including those involving clot formation (e.g., heart attack and stroke).

The antithrombotic effects of omega-3s are attributed to their ability to alter the composition of cell membranes in platelets, endothelial cells, and red blood cells, thus affecting the synthesis of eicosanoids (signaling molecules) that regulate clotting and inflammation. However, while these effects are scientifically validated, the degree of benefit for blood clot prevention in the general population is considered moderate, and omega-3s are not a replacement for anticoagulant medications when clinically indicated. The American Heart Association recommends the consumption of fatty fish like sardines twice a week for cardiovascular health, which includes clot prevention benefits.

In summary, there is scientific evidence supporting the use of sardines for blood clot prevention, primarily due to their omega-3 content, but the strength of the evidence is moderate and should be considered as part of a broader cardiovascular risk reduction strategy.

More about sardines
More about Blood Clots (prevention of)